mRNA Victoria

Last week, mRNA Victoria proudly hosted its first-ever GrantCon symposium.   GrantCon was an opportunity for us to bring together many of our grant recipients to exchange information and knowledge, identify possibilities for collaboration, and explore opportunities for efficient resource utilisation among participants with similar research goals. It was also a great opportunity for us at mRNA Victoria to hear from each of our grant recipients and see how their project is tracking.    We were thrilled to feature a couple of highlight presentations, the Victorian mRNA Innovation Hub (VMIH) at the Monash Institute of Pharmaceutical Sciences, and the platform application projects from the Monash University Biomedicine Discovery Institute (Novel Enzymes), the Hudson Institute of Medical Research (RNAte platform), Messenger Bio (Preclinical mRNA manufacturing), Monash Institute of Pharmaceutical Sciences (RNA engineering toolbox). Additionally, we hope the industry panel session with speakers from BioCurate Pty Ltd, CSL, Moderna and BioNTech SE, provided invaluable insights on navigating pathways to translation.   We look forward to being able to host another GrantCon in the future and thank all those who attended. We hope you found the event as inspiring and informative as we did. #symposium #mRNAresearch #mRNA #translation #grants

Thank you to all those that attended the recent BioMelbourne Network BioForum: BioNTech - From Concept to Clinical Trials, held on November 28th in Melbourne. This event highlighted the collaboration between BioNTech SE and mRNA Victoria, including the establishment of the BioNTech Innovation Centre in Melbourne and a GMP mRNA manufacturing facility, under construction at La Trobe University.   A special thank you to our speakers, Dr Sarah Herridge, Joshua Marks, Vickie Yan and Dr John Power, for their inspiring contributions, and to our facilitator, Dr Jane Leong, for guiding the discussion.   This event showcased the pivotal role Victoria is playing in driving global mRNA innovation and highlighted the potential of mRNA to revolutionise healthcare by developing new vaccines and therapeutics.   #BioForum #BioNTech #mRNA #Innovation #Healthcare #Melbourne #ClinicalTrials

Only a couple of days left to sign up for the BioMelbourne Network Lecture - BioNTech: From Concept to Clinical Trials.   Facilitated by Dr Jane Leong, Director, Development, Australian Centre for Artificial Intelligence in Medical Innovation, La Trobe University, the speakers will explore pathways for translating mRNA research into clinical-grade products, how these developments are shaping the future of healthcare, and the role Victoria is playing in driving this global innovation.   ➡️ Dr John Power, Senior Director Ecosystem Development and R&D Production, BioNTech Australia ➡️ Dr Sarah Herridge, Director, Research and Scientific Affairs, BioNTech Australia ➡️ Joshua Marks, Country Clinical Associate Director, BioNTech Australia   📅 28 November 2024, 3:45 pm - 6:00 pm ➡️ https://lnkd.in/gRF__bc6   #mRNA #biotech #research #innovation #mRNAvaccines #clinicaltrials #BioNTech

mRNA Victoria was delighted to attend the launch of the newly established Collaborative Centre for Genomic Cancer Medicine, a joint venture between the Peter MacCallum Cancer Centre and the University of Melbourne. This groundbreaking initiative brings together leading experts in cancer care and genomic research to drive innovation and advancements in cancer treatment and patient care. The centre will focus on integrating genomic medicine into standard cancer care, enhancing early cancer detection, genetic-risk prediction, and personalised treatment plans. Using a simple blood test, the centre will be able to create personalised cancer treatment plans for each patient. This collaboration aims to bridge the gap between research and clinical application, ensuring that patients receive the most effective and tailored treatments. The centre is focused on promoting equity in access to care, so that all patients have access to the latest advancements in cancer treatment and care, regardless of their location. Congratulations to everyone involved in making this vision a reality! #CancerResearch #HealthcareInnovation #mRNAVictoria #Collaboration #GenomicMedicine #CancerCare #MelbourneResearch #VCCCAlliance #PeterMac #UniversityofMelbourne #Parkville #Victoria For more information, visit: https://lnkd.in/gXQ3uJSe

Join mRNA Victoria and BioNTech SE as we partner with BioMelbourne Network to deliver a BioForum event.   The lecture, ‘BioNTech: From Concept to Clinical Trials’, will cover pathways to translate mRNA research into clinical-grade products suitable for clinical trials. It will also discuss partnership opportunities with BioNTech’s Innovation Centre and clinical manufacturing facility in Melbourne.   Details and registration information for the event can be found here:   📅 28 November 2024 🕓 3:45 pm - 6:00 pm, including networking ➡️ https://lnkd.in/gRF__bc6   #mRNA #biotech #research #innovation #mRNAvaccines #clinicaltrials

We were honoured to attend the 2024 Graeme Clark Oration hosted by the Convergence Science Network. This prestigious event celebrates the pioneering efforts in biomedical sciences and showcases the remarkable advancements in health and medical research.   The evening featured an inspiring oration by Dr. Robert Langer, a distinguished Institute Professor at Massachusetts Institute of Technology and cofounder of over 40 companies, including Moderna, who shared his groundbreaking work in advanced drug delivery systems and nanotechnology. His insights into the future of healthcare and his journey as a prolific entrepreneur were truly enlightening. His perseverance in tackling problems that other researchers deemed too hard to solve is inspiring and has led to his biggest successes.   The event was a fantastic opportunity to engage with innovative ideas and celebrate the legacy of Professor Graeme Clark, whose work has transformed the lives of over 700,000 people worldwide.   #GraemeClarkOration #BiomedicalScience #Healthtech #Innovation #mRNAVictoria #ConvergenceScienceNetwork #MIT

mRNA Victoria was thrilled to attend the 2025 Women in Leadership Awards Celebration hosted by BioMelbourne Network. This event is a significant platform for recognising and celebrating the incredible achievements of women in leadership roles within the healthtech industry.   The event honoured the trailblazing women who are breaking barriers and driving impactful change within the industry. The event featured a keynote presentation by Dr. Emma Ball, Head of Ecosystem Development at Illumina, and heard inspiring stories from 2024 awardees, Professor Mimi Tang, Murdoch Children's Research Institute (MCRI); Professor Michelle McIntosh, Monash University; and Dr Amanda Vrselja, Brandon BioCatalyst.   It was a great opportunity to connect with industry leaders, past award recipients, and the broader BioMelbourne Network community. Let’s celebrate the achievements of women in leadership and continue to promote diversity and inclusion in our sector.   #WomenInLeadership #Healthtech #DiversityAndInclusion #mRNAVictoria #BioMelbourneNetwork

mRNA Victoria was excited to join the 3rd Annual Advances in mRNA Science (AIMS) conference this week.   This international conference brought together industry and academic professionals to explore the latest advancements in mRNA medicines.   Last night, our CEO, Phoebe Dunn, was joined by Professor Trent Munro from the The University of Queensland and Dr Darren Saunders, Head of the RNA Australia Initiative from the Office of the NSW Chief Scientist & Engineer, to discuss “How do you energise an ecosystem around mRNA”.   Thank you to Professor Damian Purcell, Chair of the 2024 AIMS steering committee and sponsors, Moderna, for an insightful two days.   #mRNA #biotech #research #innovation #mRNAvaccines

Reminder to sign up to the next BioMelbourne Network Lecture - BioNTech: From Concept to Clinical Trials   Join us for this compelling lecture on the pathways to translate mRNA research into clinical-grade products suitable for clinical trials. Discover how these developments are shaping the future of healthcare, and the role Victoria is playing in driving this global innovation.   The lecture will be held on 28 November 2024 from 3.45pm until 6pm. The event will include presentations from BioNTech SE’s Australia team, followed by a panel discussion, Q&A and networking drinks.   Read more and sign up at: https://lnkd.in/gRF__bc6 #mRNA #biotech #research #innovation #mRNAvaccines

Congratulations to exteRNA!   We are thrilled to celebrate the incredible achievement of Melbourne-based biotech startup, exteRNA, for securing $11 million in seed funding to advance their groundbreaking cancer therapies. This milestone is a testament to their innovative approach in targeting RNA processing pathways to develop novel small-molecule therapeutics.   Led by the expertise of Professor Vihandha Wickramasinghe of the Peter MacCallum Cancer Centre and Professor Guillaume Lessene of WEHI (Walter and Eliza Hall Institute of Medical Research), exteRNA is poised to make significant strides in the fight against cancer. Their work exemplifies the cutting-edge research and collaboration that drives Victoria’s biotech community forward.   Through the mRNA Victoria Research Acceleration Fund, mRNA Victoria was proud to support Professor Wickramasinghe's project to develop nuclear mRNA targeting therapeutics for cancer with a $500,000 grant. We look forward to seeing the transformative impact of exteRNA’s therapies on patients’ lives and are proud to support their journey towards clinical success. 👏 Well done, exteRNA 👏   #Biotech #CancerResearch #Innovation #RNAProcessing #mRNAVictoria #MelbourneBiotech